Disease duration (years), mean±SD 8.1 ±6.6
Underweight (BMI ≤18.5), n. (%) 9 (10 %)
Normal weight (BMI >8.5 <25), n. (%) 49 (55 %)
Overweight (BMI ≥25 ≤30), n. (%) 26 (29 %)
Obese (BMI >30), n. (%) 5 (6 %)
Diabetes Mellitus, n. (%) 1 (9 %)
Dyslipidemia, n. (%) 11 (12 %)
Tot-Cholesterol/HDL, mean ±SD 3.3 ±1.0
Framingham risk score, mean ±SD 3.7 ±2.9
Previous smokers, n (%) 5 (6 %)
Arterial Hypertension, n (%) 8 (7 %)
Active patients with disease activity index ≥3 ESSG, n. (%) 24 (27 %)
Erythrocyte Sedimentation Rate (mm/h), mean±SD 19 ± 14
C-Reactive Protein (mg/l), mean±SD 4.3 ± 5
Limited cutaneous SSc, n. (%) 74 (83 %)
Interstitial lung disease, n. (%) 51 (57 %)
Esophageal Involvement, n. (%) 79 (89 %)
Bowel incontinence, n. (%) 2 (3 %)
Active digital ulcers, n. (%) 18 (20 %)
Digital pitting scars, n. (%) 55 (62 %)
Calcinosis, n. (%) 79 (89 %)
Renal Involvement, n. (%) 5 (6 %)
Pulmonary Arterial Hypertension, n. (%) 7 (8 %)
Capillaroscopy scleroderma pattern, n. (%) Early 6 (7 %)
Active 49 (55 %)
Late 34 (38 %)